Address
Ambit Biosciences Inc
4215 Sorrento Valley Boulevard
San Diego, CA 92121
United States
Phone
Website
VCID: 115478
Profile
Corporate information
Official name
Ambit Biosciences Incorporated
Registration country
Investment activity status
Active investor
Company type
A biopharmaceutical company engaged in the discovery and development of small molecule kinase inhibitors for the treatment of cancer.Funding
Funding rounds
(10 Jun 2011)
| Investor | Profile | Country | Notes | |
|---|---|---|---|---|
|
OrbiMed Advisors LLC | American investment firm focused on making public and private investments in the healthcare and biotechnology industries. | United States |
(10 Jun 2011)
| Investor | Profile | Country | Notes | |
|---|---|---|---|---|
|
Roche Venture Fund | The corporate venture fund of the healthcare company Roche | Switzerland |
(31 Dec 2007)
| Investor | Profile | Country | Notes | |
|---|---|---|---|---|
|
Apposite Capital LLP | Independent private equity investor focussed on healthcare sector | United Kingdom |
| Investor | Profile | Country | Notes | |
|---|---|---|---|---|
|
Radius Ventures LLC | A venture capital firm focused on health and life sciences companies | United States |
Cap Table
Current and past shareholders
| Investor | Contacts | Round | |
|---|---|---|---|
|
|
Apposite Capital LLP Independent private equity investor focussed on healthcare sector |
+44 (20) 7090-6190 |
Series D |
|
Avalon Ventures |
+1 (858) 348-2180 |
N/A |
|
Forward Ventures Services LLC |
+1 (858) 677-6077 |
Series D |
|
GIMV NV |
+32 (3) 290-2100 |
Series D |
|
GrowthWorks Capital Ltd |
+1 (306) 242-1023 |
Series D |
|
MedImmune Ventures Inc |
+1 (301) 398-4259 |
Series D |
|
|
OrbiMed Advisors LLC American investment firm focused on making public and private investments in the healthcare and biotechnology industries. |
+1 (212) 739-6400 |
Series D |
|
|
Radius Ventures LLC A venture capital firm focused on health and life sciences companies |
+1 (212) 897-7778 |
N/A |
|
|
Roche Venture Fund The corporate venture fund of the healthcare company Roche |
Series D |